Xeris Biopharma Holdings Inc (XERS) Implied Volatility Current

Tracking XERS implied volatility helps you identify when options premiums on Xeris Biopharma Holdings Inc are historically cheap or expensive, and where the best trades are hiding. Xeris Biopharma Holdings Inc implied volatility reflects the market's expectation of future price movement: when XERS IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Xeris Biopharma Holdings Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For XERS, tracking metrics like XERS IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on XERS signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect.

The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where XERS implied volatility sits today versus where it has been. Our scanner ranks Xeris Biopharma Holdings Inc implied volatility against its historical range, surfaces extremes in XERS IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Xeris Biopharma Holdings Inc IV is rich or cheap — measure it, then act on it.